Literature DB >> 2206480

A probability representation for phase information from multiwavelength anomalous dispersion.

A Pähler1, J L Smith, W A Hendrickson.   

Abstract

A probability distribution function, cast in the representation of Hendrickson & Lattman [Acta Cryst. (1970), B26, 136-143], has been derived for the phase information from measurements of multiwavelength anomalous diffraction (MAD). This probability function readily permits one to determine figure-of-merit weights similar to those used in isomorphous replacement, and the coefficients that characterize this distribution function facilitate the combining of MAD phasing with results from other sources of phase information. This probability representation was derived in the course of a structural analysis of selenobiotinyl streptavidin from MAD data and applications have also been made in the structure determinations of interleukin-1 alpha and a drug complex with brominated DNA.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2206480     DOI： 10.1107/s0108767390002379

Source DB:  PubMed          Journal:  Acta Crystallogr A        ISSN： 0108-7673            Impact factor:   2.290


  13 in total

1.  Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environment.

Authors:  Andrea R Conlan; Mark L Paddock; Christina Homer; Herbert L Axelrod; Aina E Cohen; Edward C Abresch; John A Zuris; Rachel Nechushtai; Patricia A Jennings
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-05-17

2.  Dimer-tetramer transition between solution and crystalline states of streptavidin and avidin mutants.

Authors:  Yael Pazy; Yael Eisenberg-Domovich; Olli H Laitinen; Markku S Kulomaa; Edward A Bayer; Meir Wilchek; Oded Livnah
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

3.  Crystal structure of an HIV-binding recombinant fragment of human CD4.

Authors:  S E Ryu; P D Kwong; A Truneh; T G Porter; J Arthos; M Rosenberg; X P Dai; N H Xuong; R Axel; R W Sweet
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

4.  Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram Syndrome 2.

Authors:  Andrea R Conlan; Herbert L Axelrod; Aina E Cohen; Edward C Abresch; John Zuris; David Yee; Rachel Nechushtai; Patricia A Jennings; Mark L Paddock
Journal:  J Mol Biol       Date:  2009-07-04       Impact factor: 5.469

Review 5.  Anomalous diffraction in crystallographic phase evaluation.

Authors:  Wayne A Hendrickson
Journal:  Q Rev Biophys       Date:  2014-02       Impact factor: 5.318

6.  Spectral X-Ray Diffraction using a 6 Megapixel Photon Counting Array Detector.

Authors:  Ryan D Muir; Nicholas R Pogranichniy; J Lewis Muir; Shane Z Sullivan; Kevin P Battaile; Anne M Mulichak; Scott J Toth; Lisa J Keefe; Garth J Simpson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-12

7.  Improved technologies now routinely provide protein NMR structures useful for molecular replacement.

Authors:  Binchen Mao; Rongjin Guan; Gaetano T Montelione
Journal:  Structure       Date:  2011-06-08       Impact factor: 5.006

8.  Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.

Authors:  X Jiang; O Gurel; E A Mendiaz; G W Stearns; C L Clogston; H S Lu; T D Osslund; R S Syed; K E Langley; W A Hendrickson
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

9.  MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone.

Authors:  Mark L Paddock; Sandra E Wiley; Herbert L Axelrod; Aina E Cohen; Melinda Roy; Edward C Abresch; Dominique Capraro; Anne N Murphy; Rachel Nechushtai; Jack E Dixon; Patricia A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

10.  Structural elements responsible for conversion of streptavidin to a pseudoenzyme.

Authors:  Yael Eisenberg-Domovich; Yael Pazy; Orit Nir; Bilha Raboy; Edward A Bayer; Meir Wilchek; Oded Livnah
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.